undamentalytics Newsletter
Sign in

Option Care Health, Inc. (OPCH) stock

Add to watchlist

Add holding +

NASDAQ: OPCH Nasdaq Health Care Services Next results ~November 4, 2026

C+ Fundamentals grade

Option Care Health, Inc. is a US-listed company in the health care services industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$36

Cash-flow model

Base case. Range ~$25–$50 across our lower- and higher-growth cases (3.6%–13.6% a year).

Price vs value

Modestly undervalued

The price is inside our value range, 12% below our base value.

Price used: $31.69, November 2, 2026

Option Care Health, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders4 buying, 2 selling5 purchases and 2 sales by directors and officers, last 12 monthsInsider trades
  • Funds204 adding, 193 cuttingOf 68 active managers that changed their stake, 35 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Option Care Health files

Where Option Care Health stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $5.69bn, up 5.9% on a year earlier, slower than the 9.3% growth a quarter earlier. Free-cash-flow margin held at 5.3%. The diluted share count is down 5.7% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 3 of our 7 financial-health checks. Our cash-flow model value is $36.67 a share, against a share price of $31.25. At that price, our model says the market is pricing in about 6.2% a year of cash-flow growth for five years, slower than the 10.6% a year revenue growth it has delivered.

Source: 10-Q filed July 29, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

Option Care Health, Inc.'s trailing-twelve-month revenue grew 5.9% year on year, with a free-cash-flow margin of 5.3%. Where it stands out: change in share count of -5.7% ranks 5 of 39 health care services companies we cover. Where it lags: change in growth rate of -3.4pp ranks 35 of 41 health care services companies we cover.

Our discounted-cash-flow model values the business at ~$36 per share in the base case (~$25–$50 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 26.0% while net income fell 0.8%: a 27pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 5.7% in a year, so each share owns more of the business.

Things to watch

  • Volatile shares. Over the past year the shares showed annualised volatility of 52% and a beta of 0.0 against the S&P 500.
  • Growth easing. The growth rate is 3.4 points lower than a quarter earlier.
  • Below peers: change in growth rate. Change in growth rate of -3.4pp ranks 35 of 41 health care services companies we cover (median +1.1pp).

Latest results: FY2026 Q2

Filed July 29, 2026
Earnings per share
$0.45 against an average estimate of $0.43: beat by 5.4%
Revenue
$1.44bn, up 1.9% on a year earlier
Share reaction
-0.1% in the first session after the results on July 29, 2026, against +0.1% for the S&P 500
Next report
November 4, 2026; average EPS estimate $0.49

Option Care Health's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-0.4%
  • 1 week+1.5%
  • 1 month+40.0%
  • This year-0.5%
  • 1 year+21.7%
  • 5 years+13.5%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$5.7B
Operating margin
5.9%
Net margin
3.7%
EPS (TTM, diluted)
$1.32

Growth

Revenue growth
+5.9%
Change in growth rate
−3.4 pts
Share count change
−5.7%

Cash

Free cash flow (TTM)
$304M
FCF margin
5.3%
Stock pay % of revenue
0.7%

Earnings

Last results
July 29, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Agreement
  2. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Option Care Health, Inc. valuation models and calculator

What the price is pricing in

The share price implies about 6.1% a year of cash-flow growth for five years.That is close to the 10.6% a year revenue growth Option Care Health has delivered.

  • Priced in6.1%
  • Last 12 months5.9%
  • 3 years a year11.3%
  • 5 years a year10.6%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($31.67, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Hold12-month view
12-month price target
~$36
Price used
$31.67close November 3, 2026
Implied change
▲ +13%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of Option Care Health, Inc.'s free cash flow after stock-based pay with after-tax interest added back ($273M, FY2026 Q2 TTM), growing 5.7% and 7.9% in the next two years (forecasts, guidance and its record), then back to 8.6% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$25–~$50 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Option Care Health, Inc.'s free cash flow after stock-based pay ( $273M, FY2026 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Option Care Health, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 7.6%: the 10-year Treasury yield (4.9%) plus a beta of 0.6 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$36 ~$25–$50 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$38 ~$30–$58 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$25 ~$16–$40 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$23 ~$19–$29 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$32 ~$23–$38 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Option Care Health, Inc. with Health Care Services in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −29%
  • Revenue growth 5 points higher ▲ +38%
  • Free-cash-flow margin 1 point lower ▼ −19%
  • Last year's free-cash-flow margin change, if it persists ▲ +19%
  • Discount rate 1 point higher ▼ −17%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $20$29$42$58$80$107
8.5% $14$20$29$41$56$76
10% $10$15$22$31$43$58

Valuation multiples over time Market data may be delayed

At fiscal year end 2016201720182019202020212022202320242025Now
Share price$4.16$11.64$14.28$14.92$15.64$28.44$30.09$33.69$23.20$31.86$31.69
Market value$390m$1.7bn$2.0bn$2.3bn$2.8bn$5.2bn$5.5bn$6.1bn$4.0bn$5.2bn$5.0bn
+ Net debt (− = net cash)$458m$463m$515m$1.3bn$1.1bn$981m$800m$744m$719m$944m$979m
Enterprise value$848m$2.1bn$2.6bn$3.6bn$3.9bn$6.1bn$6.3bn$6.8bn$4.7bn$6.1bn$6.0bn
Multiples
Price / sales 0.4x0.9x1.0x1.0x0.9x1.5x1.4x1.4x0.8x0.9x0.9x
Price / earnings —n/m———36.8x36.4x22.8x18.9x25.1x24.0x
Price / free cash flow —128.5x—n/m28.2x28.2x23.6x18.4x13.9x24.0x16.5x
EV / EBITDA 76.8x34.3x33.4x67.5x21.4x24.2x20.9x18.2x12.4x15.2x14.9x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

48 /100

Moderate moat

How hard Option Care Health's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 12 / 20

    Cash operating profit has been a median 9.6% of total assets over 7 years.

  • Pricing power 7 / 20

    Gross margin has been a median 22.0%, moving by 3.5 percentage points (standard deviation) across 10 years.

  • Durability 3 / 20

    Operating margin has been a median 5.4%; its worst year was 0.9%.

  • Cash conversion 11 / 20

    Free cash flow was positive in 8 of 9 years, at a median 4.4% of revenue.

  • Discipline 20 / 20

    The diluted share count fell 13.3% over five years; stock-based pay has been a median 0.3% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (52 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, before the open. Analysts expect revenue of $1.5bn and EPS of $0.49 (range $0.47 to $0.50) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $1.88 +9% $5.8bn +2%
Next $2.08 +11% $6.1bn +6%

Next year's EPS estimate has moved +1.6% in 90 days, across 11 analysts.

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.43 $0.45 +5.4%
Mar 2026 $0.37 $0.40 +8.1%
Dec 2025 $0.47 $0.46 −1.8%
Sept 2025 $0.43 $0.45 +4.7%

Adjusted EPS as companies report it, against the average analyst estimate.

How our valuation uses these forecasts

Our cash-flow model grows Option Care Health, Inc.'s revenue by +5.7% next year and +7.9% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+4.4%, weight 68%) and the company's own record (+8.6%, weight 32%) . How the weights are set.

Analyst recommendations

11 analysts, Oct 2026
Buy00%
Hold11100%
Sell00%

Monthly trend

  1. Oct 20261111
  2. Sep 202644513
  3. Aug 202644513
  4. Jul 202644513

Counts of recommendations published by analysts covering Option Care Health, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
8.0%
of tradable shares
Days to cover
4.12
at average volume
Short interest, 1 month
−32%
to September 30, 2026
Held by institutions
—
of shares
Held by insiders
1.3%
of shares
Employees
8,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +21.7%

$26.03 on October 31, 2025 to $31.69

ThenNowEffect
Revenue (last 12 months) $5.4bn $5.7bn +5.9%
Net margin 3.9% 3.7% −6.4%
P/E multiple 20.7x 24.0x +15.7%
Share count 168m 159m +6.1%

Biggest factor: p/e multiple.

Last 3 years +10.8%

$28.59 on November 3, 2023 to $31.69

ThenNowEffect
Revenue (last 12 months) $4.1bn $5.7bn +37.8%
Net margin 5.8% 3.7% −36.6%
P/E multiple 21.7x 24.0x +10.4%
Share count 182m 159m +14.9%

Biggest factor: net margin.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
OPCH+82%+6%+12%−31%+37%−1%
Industry peers (median)−3%−28%+6%−6%−9%+15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
OPCH58%50%67%42%50%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
OPCH−22%−23%−25%−37%−26%−47%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 3, 2015: 69% from October 5, 2016 to December 22, 2016. Getting back needed a 227% gain, reached on November 26, 2018, 704 days after the low.

Price behaviour

52-week range
$19.52 – $36.59
From 52-week high
−13.4%
vs 50-day average
+18.8%
vs 200-day average
+20.5%
Volatility (1 year)
52%
Beta vs S&P 500
0.01

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
3 up, 9 down
typical move ±8.8%
After a week
4 up, 8 down
typical move ±10.7%
After a month
6 up, 6 down
typical move ±12.0%
Results releasedNext dayS&P 500 next day5 days21 days
July 29, 2026 −0.1% +0.1% +5.4% +6.7%
April 30, 2026 −25.5% +1.3% −22.8% −23.9%
February 24, 2026 −6.9% +1.6% −13.5% −21.1%
January 12, 2026 +9.3% 0.0% +12.5% +9.0%
October 30, 2025 −9.2% −0.8% −5.7% +7.9%
July 30, 2025 −2.6% −0.5% −7.4% −4.6%
April 29, 2025 −2.0% +0.7% −0.7% −2.2%
February 26, 2025 +1.7% −1.5% +6.0% +7.9%
January 13, 2025 +19.7% +0.3% +22.8% +32.8%
October 30, 2024 −24.5% −2.3% −23.0% −22.0%
July 31, 2024 −1.9% +0.2% −6.8% +1.0%
April 23, 2024 −1.6% +1.1% −1.7% −4.5%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Option Care Health, Inc.’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: fundamentals grade C+ (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: the shares trade below our fair value: a collar caps upside the model expects.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Option Care Health, Inc. in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Option Care Health, Inc.
$4B $4.5B $5B $5.5B $6B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $4.2B Revenue (TTM), FY23 Q4: $4.3B Revenue (TTM), FY24 Q1: $4.4B Revenue (TTM), FY24 Q2: $4.6B Revenue (TTM), FY24 Q3: $4.8B Revenue (TTM), FY24 Q4: $5B Revenue (TTM), FY25 Q1: $5.2B Revenue (TTM), FY25 Q2: $5.4B Revenue (TTM), FY25 Q3: $5.5B Revenue (TTM), FY25 Q4: $5.6B Revenue (TTM), FY26 Q1: $5.7B Revenue (TTM), FY26 Q2: $5.7B $5.7B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $4.2B
FY23 Q4 $4.3B
FY24 Q1 $4.4B
FY24 Q2 $4.6B
FY24 Q3 $4.8B
FY24 Q4 $5B
FY25 Q1 $5.2B
FY25 Q2 $5.4B
FY25 Q3 $5.5B
FY25 Q4 $5.6B
FY26 Q1 $5.7B
FY26 Q2 $5.7B
Revenue growth, TTM YoY Option Care Health, Inc.
0% 5% 10% 15% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 9.4% Revenue growth, TTM YoY, FY23 Q4: 9.1% Revenue growth, TTM YoY, FY24 Q1: 9.6% Revenue growth, TTM YoY, FY24 Q2: 11.1% Revenue growth, TTM YoY, FY24 Q3: 13.6% Revenue growth, TTM YoY, FY24 Q4: 16.2% Revenue growth, TTM YoY, FY25 Q1: 17.0% Revenue growth, TTM YoY, FY25 Q2: 17.1% Revenue growth, TTM YoY, FY25 Q3: 15.8% Revenue growth, TTM YoY, FY25 Q4: 13.0% Revenue growth, TTM YoY, FY26 Q1: 9.3% Revenue growth, TTM YoY, FY26 Q2: 5.9% 5.9%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 9.4%
FY23 Q4 9.1%
FY24 Q1 9.6%
FY24 Q2 11.1%
FY24 Q3 13.6%
FY24 Q4 16.2%
FY25 Q1 17.0%
FY25 Q2 17.1%
FY25 Q3 15.8%
FY25 Q4 13.0%
FY26 Q1 9.3%
FY26 Q2 5.9%
Operating margin (TTM) Option Care Health, Inc.
5.5% 6% 6.5% 7% 7.5% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 7.1% Operating margin (TTM), FY23 Q4: 7.3% Operating margin (TTM), FY24 Q1: 7.2% Operating margin (TTM), FY24 Q2: 6.9% Operating margin (TTM), FY24 Q3: 6.7% Operating margin (TTM), FY24 Q4: 6.4% Operating margin (TTM), FY25 Q1: 6.4% Operating margin (TTM), FY25 Q2: 6.2% Operating margin (TTM), FY25 Q3: 6.0% Operating margin (TTM), FY25 Q4: 6.0% Operating margin (TTM), FY26 Q1: 5.8% Operating margin (TTM), FY26 Q2: 5.9% 5.9%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 7.1%
FY23 Q4 7.3%
FY24 Q1 7.2%
FY24 Q2 6.9%
FY24 Q3 6.7%
FY24 Q4 6.4%
FY25 Q1 6.4%
FY25 Q2 6.2%
FY25 Q3 6.0%
FY25 Q4 6.0%
FY26 Q1 5.8%
FY26 Q2 5.9%
FCF margin (TTM) Option Care Health, Inc.
3% 4% 5% 6% 7% 8% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 7.7% FCF margin (TTM), FY23 Q4: 7.7% FCF margin (TTM), FY24 Q1: 3.9% FCF margin (TTM), FY24 Q2: 4.2% FCF margin (TTM), FY24 Q3: 6.1% FCF margin (TTM), FY24 Q4: 5.8% FCF margin (TTM), FY25 Q1: 6.7% FCF margin (TTM), FY25 Q2: 4.5% FCF margin (TTM), FY25 Q3: 4.0% FCF margin (TTM), FY25 Q4: 3.8% FCF margin (TTM), FY26 Q1: 3.8% FCF margin (TTM), FY26 Q2: 5.3% 5.3%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 7.7%
FY23 Q4 7.7%
FY24 Q1 3.9%
FY24 Q2 4.2%
FY24 Q3 6.1%
FY24 Q4 5.8%
FY25 Q1 6.7%
FY25 Q2 4.5%
FY25 Q3 4.0%
FY25 Q4 3.8%
FY26 Q1 3.8%
FY26 Q2 5.3%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Option Care Health took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $5.6B
  2. Cost of revenue $4.6B · 80.7%
  3. Gross profit $1.1B · 19.3%
  4. Selling, general and admin $682M · 12.1%
  5. Other operating costs $67.5M · 1.2%
  6. Operating income $338M · 6.0%
  7. Income tax $75.3M · 1.3%
  8. Interest and other $55M · 1.0%
  9. Net income $208M · 3.7%

Shares of revenue. Source: Option Care Health's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2007 Dec 2007 2008 Dec 2008 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 1,198 1,402 1,330 1,639 1,818 936 1,828 1,940 2,310 3,033 3,439 3,945 4,302 4,998 5,650 5,694
Gross profit 137 142 158 161 215 262 446 422 513 682 780 867 981 1,013 1,088 1,085
EBITDA 13 −79 20 13 32 11 62 76 53 182 254 301 374 383 405 402
Operating income 9 −84 15 8 26 −11 27 38 −0 111 191 240 315 322 338 334
Net income 3 −74 54 −69 8 −43 4 −6 −76 −8 140 151 267 212 208 210
Diluted EPS $0.09 −$1.93 $1.36 −$1.37 $0.14 −$0.55 $0.03 −$0.04 −$0.49 −$0.04 $0.77 $0.83 $1.48 $1.23 $1.27 $1.32
Growth (year on year)
Revenue — +17.0% −5.2% +23.2% +10.9% −48.5% +95.4% +6.1% +19.1% +31.3% +13.4% +14.7% +9.1% +16.2% +13.0% +5.9%
EBITDA — — — — — — — +23.2% −30.1% +241.1% +39.5% +18.5% +24.3% +2.4% +5.9% +1.1%
Operating income — — — — — — — — — — +72.3% +25.9% +31.0% +2.3% +5.0% −0.1%
Net income — — — −227.8% — — — — — — — +7.6% +77.4% −20.7% −2.0% −0.8%
Diluted EPS — — — −200.7% — — — — — — — +7.8% +78.3% −16.9% +3.3% +5.2%
Margins
Gross margin 11.4% 10.1% 11.9% 9.8% 11.8% 28.0% 24.4% 21.8% 22.2% 22.5% 22.7% 22.0% 22.8% 20.3% 19.3% 19.1%
EBITDA margin 1.1% −5.6% 1.5% 0.8% 1.8% 1.2% 3.4% 3.9% 2.3% 6.0% 7.4% 7.6% 8.7% 7.7% 7.2% 7.1%
Operating margin 0.7% −6.0% 1.2% 0.5% 1.4% −1.2% 1.5% 2.0% −0.0% 3.7% 5.5% 6.1% 7.3% 6.4% 6.0% 5.9%
Net margin 0.3% −5.3% 4.1% −4.2% 0.4% −4.6% 0.2% −0.3% −3.3% −0.3% 4.1% 3.8% 6.2% 4.2% 3.7% 3.7%
Free-cash-flow margin — — 1.7% −1.3% 1.5% — 0.7% −0.1% 0.5% 3.3% 5.3% 5.9% 7.7% 5.8% 3.8% 5.3%
Cash flow
Cash from operations 24 −9 23 −21 27 −43 38 24 39 127 209 268 371 323 258 347
Capital spending — — 0 0 0 — 25 26 28 27 26 35 42 36 41 43
Free cash flow — — 23 −21 27 — 13 −2 11 101 183 232 329 288 217 304
Stock-based pay 3 4 3 3 4 2 1 2 4 3 10 17 30 36 40 39
Free cash flow after stock pay — — 19 −25 22 — 11 −4 7 98 173 215 299 252 177 265
Balance sheet
Cash 0 0 0 0 0 10 39 36 67 99 119 294 344 413 233 194
Total debt 0 50 61 306 293 468 503 552 1,337 1,162 1,100 1,094 1,088 1,132 1,176 1,173
Net debt (negative = net cash) 0 50 61 306 293 458 463 515 1,270 1,062 981 800 744 719 944 979
Diluted shares 38m 38m 40m 50m 55m 94m 143m 143m 156m 181m 181m 182m 180m 173m 163m 159m
Returned to shareholders
Buybacks — — — — — — — — — — 0 0 250 253 310 —
Total returned — — — — — — — — — — 0 0 250 253 310 —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

3 of 7 checks passed · June 30, 2026
What it owns · $3.4bn
Short-term assets $1.2bnLonger-term assets $2.2bn
What it owes, and who funded it · $3.4bn
Short-term liabilities $819mLonger-term liabilities $1.3bnShareholders' equity $1.3bn
  • Short-term assets cover short-term liabilities $1.2bn of assets due within a year against $819m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.2bn short-term assets against $1.3bn of longer-dated liabilities.
  • More cash than debt $194m of cash against $1.2bn of debt.
  • Debt below 40% of shareholders' equity Debt is 92% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 90% to 92% over five years.
  • A year's operating cash flow covers at least 20% of debt $347m of operating cash flow against $1.2bn of debt.
  • Operating profit covers interest at least five times over Operating income of $334m against $54m of interest.

From Option Care Health, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Buybacks, last 3 fiscal years
$813M
Diluted share count
−5.7%
year over year
Sales & admin spending
12.0%
of revenue
Days sales outstanding
33 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care services
Last 12 months unless stated OPCH AGL ASTH AMN DGX CHE Median
Revenue, last 12 months $5.7bn $5.9bn $3.8bn $3.4bn $11.8bn $2.7bn $1.2bn
Revenue growth, last 12 months 5.9% 0.3% 58.9% 24.0% 9.1% 5.2% 7.3%
Revenue growth, 3-year average 11.3% 22.9% 43.7% −7.8% 8.4% 6.1% 11.3%
Revenue growth, latest quarter 1.9% 7.2% 48.5% 2.3% 10.0% 10.6% 8.5%
Gross margin 19.1% — 21.5% 27.8% 33.1% 33.5% 27.9%
Operating margin 5.9% −5.2% 2.6% 5.8% 14.6% 13.9% 2.3%
Operating margin, 3-year average 6.3% −5.5% 3.8% 0.5% 13.9% 14.4% 2.3%
Net margin 3.7% −3.9% 1.1% 3.1% 9.5% 10.6% 1.2%
Cash from operations / revenue 6.1% −1.2% 2.8% 13.7% 16.5% 13.6% 6.1%
Free-cash-flow margin 5.3% −1.4% 2.5% 12.8% 11.6% 11.1% 5.1%
Free-cash-flow margin, 3-year average 4.7% −1.9% 3.5% 9.5% 11.7% 11.6% 3.6%
Stock pay / revenue 0.7% 0.8% 1.1% 0.9% 0.7% — 1.1%
Change in share count −5.7% 1.8% 1.8% 2.1% −1.1% −8.3% 0.3%

Median of all 41 companies we cover in health care services. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

41 health care services companies
Measure Company Peer median Rank
Revenue growth Growth 5.9% 7.3% 25 of 41
Change in growth rate Growth -3.4pp +1.1pp 35 of 41
Gross margin Profitability 19.1% 29.0% 20 of 27
Operating margin Profitability 5.9% 2.6% 14 of 40
Net margin Profitability 3.7% 1.2% 15 of 41
Free-cash-flow margin Cash generation 5.3% 5.1% 19 of 40
Stock pay as % of revenue Cash generation 0.7% 0.9% 9 of 35
Long-term debt as % of assets Balance sheet 34.1% 27.7% 22 of 31
Change in share count Balance sheet -5.7% 0.4% 5 of 39
Days sales outstanding Balance sheet 33 days 39 days 8 of 31

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$3.3B
Institutions reporting
370
Shares held vs prior quarter
▼ 5.5%
Positions opened / closed
73 / 70

Top buyers and sellers, Q2 2026: 204 institutions bought and 193 sold ; the biggest buyer was Blackrock, Inc (+2.2M shares) and the biggest seller FMR LLC (−4.6M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $464M 22.1M 14.0% ▲ 11.1%
Wellington Management Group LLP $247M 11.8M 7.5% ▼ 1.0%
Vanguard Portfolio Management LLC $174M 8.3M 5.3% ▲ 2.6%
Fuller & Thaler Asset Management, Inc. $156M 7.5M 4.7% ▲ 4.6%
Vanguard Capital Management LLC $148M 7.1M 4.5% ▲ 0.7%
Durable Capital Partners LP $129M 6.2M 3.9% ▼ 31.4%
State Street Corp $129M 6.1M 3.9% ▲ 4.5%
Arrowstreet Capital, Limited Partnership $125M 6.0M 3.8% ▲ 41.2%
Dimensional Fund Advisors LP $114M 5.4M 3.5% ▲ 40.6%
Geode Capital Management, LLC $93.7M 4.5M 2.8% ▲ 5.2%
Millennium Management LLC $54.9M 2.6M 1.7% ▲ 59.6%
Charles Schwab Investment Management Inc $51.7M 2.5M 1.6% ▼ 1.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Option Care Health, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $2.9M 5 trades by 4 insiders, last 12 months Insider sales History → $1.2M 2 trades by 2 insiders · 0% under pre-set plans
Net ▲ $1.7M net buying
Insider Date Trade Shares Price Value
Sullivan Timothy P Director May 7, 2026 Buy 24,154 $20.69 $499,746
Rademacher John Charles Chief Executive Officer May 4, 2026 Buy 12,500 $21.18 $264,750
Sethna Meenal Chief Financial Officer May 4, 2026 Buy 16,225 $20.16 $327,096
Kraemer Harry M Jansen Jr Director May 4, 2026 Buy 36,610 $21.41 $783,820
Bavaro Michael Chief Human Resources Officer February 27, 2026 Sell 6,000 $33.00 $198,000
Pate R Carter Director February 27, 2026 Sell 30,287 $32.05 $970,698
Kraemer Harry M Jansen Jr Director November 3, 2025 Buy 38,000 $25.98 $987,240

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 4 trades and filings

No trades in Option Care Health, Inc. disclosed in the last 12 months; 4 earlier trades on record.

  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded October 31, 2025, filed November 21, 2025
  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded October 30, 2025, filed November 21, 2025
  • Lisa C. McClain(R-MI 9):Purchase, $1,001 - $15,000, traded October 30, 2025, filed November 21, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

  • July 29, 2026
  • April 30, 2026
  • February 24, 2026
  • January 12, 2026
  • October 30, 2025
  • July 30, 2025

Recent SEC filings

Data status

When each part of this page on Option Care Health, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Option Care Health, Inc. in brief

What does Option Care Health, Inc. do?
Option Care Health, Inc. is a US-listed company in the health care services industry. Its financial year ends in December.
What is Option Care Health, Inc.'s stock ticker?
Option Care Health, Inc. trades under the ticker OPCH on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Option Care Health, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Option Care Health, Inc. reported revenue of $5.7B, 5.9% higher than a year earlier, according to its SEC filings.
What is Option Care Health, Inc.'s free cash flow?
Option Care Health, Inc.'s free-cash-flow margin is 5.3% of revenue over the trailing twelve months, ranking 19 of the 40 health care services companies we cover.
What is Option Care Health, Inc.'s fair value (intrinsic value) per share?
Our discounted-cash-flow model of Option Care Health, Inc.'s free cash flow after stock-based pay gives ~$36 per share in the base case, and ~$25–$50 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Option Care Health, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Wellington Management Group LLP and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Option Care Health, Inc.'s market cap?
On November 2, 2026, Option Care Health, Inc.'s market capitalisation was about $5B, with a price-to-earnings ratio of 24.0 and net debt of $979M. Market figures come from third-party market data and may be delayed.
How much debt does Option Care Health, Inc. have?
Option Care Health, Inc.'s debt-to-equity ratio is 92.0%, from its latest balance sheet (90.1% five years earlier). The financial health section below sets out its other solvency checks.
Who are Option Care Health, Inc.'s competitors?
In our Health Care Services peer group, the companies closest to Option Care Health, Inc. are Agilon Health, Inc., Astrana Health, Inc., AMN Healthcare Services Inc, Quest Diagnostics and Chemed Corp. The side-by-side comparison below sets their revenue, margins and growth against Option Care Health, Inc.'s.
Are insiders buying or selling Option Care Health, Inc. stock?
Over the last 12 months, Option Care Health, Inc.'s directors and officers reported 5 open-market purchases and 2 sales on Form 4. The insider trading page charts every trade.
When is Option Care Health, Inc.'s next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Option Care Health, Inc. announces its own schedule.